PT  - JOURNAL ARTICLE
AU  - J. G. García de Alcañíz
AU  - V. López-Rodas
AU  - E. Costas
TI  - Groundbreaking predictions about COVID-19 pandemic duration, number of infected and dead: A novel mathematical approach never used in epidemiology
AID  - 10.1101/2020.08.05.20168781
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.05.20168781
4099  - http://medrxiv.org/content/early/2020/08/06/2020.08.05.20168781.short
4100  - http://medrxiv.org/content/early/2020/08/06/2020.08.05.20168781.full
AB  - Hundreds of predictions about the duration of the pandemic and the number of infected and dead have been carried out using traditional epidemiological tools (i.e. SIR, SIRD models, etc.) or new procedures of big-data analysis. However, the extraordinary complexity of the disease and the lack of knowledge about the pandemic (i.e. R value, mortality rate, etc.) create uncertainty about the accuracy of these estimates. However, several elegant mathematical approaches, based on physics and probability principles, like the Delta-t argument, Lindy’s Law or the Doomsday principle-Carter’s catastrophe, which have been successfully applied by scientists to unravel complex phenomena characterized by their great uncertainty (i.e. Human race’s longevity; How many more humans will be born before extinction) allow predicting parameters of the Covid-19 pandemic. These models predict that the COVID-19 pandemic will hit us until at least September-October 2021, but will likely last until January-September 2022, causing a minimum of 36,000,000 infected and most likely 60,000,000, as well as 1,400,000 dead at best and most likely 2,333,000.Competing Interest StatementThe authors have declared no competing interest.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was required to develop this paperAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Complutense University MadridAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data was obtained from public web pages and links are available in the manuscript